Ana Claudia C. de Ornelas Maia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Claudia C. de Ornelas Maia has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Cardoso de Oliveira e Silva
Universidade Federal do Rio de Janeiro
3 shared publications Antonio Egidio Nardi
3 shared publications- Antonio Egidio Nardi
Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
3 shared publications Adriana Cardoso Silva
2 shared publications- Elisabete Rodrigues Nascimento
Laboratory of Panic and Respiration - Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Brazil
2 shared publications Adriana Cardoso de Oliveira e Silva
1 shared publication
Latest Publications
- 1 August 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 181, 96-100
Sexual dysfunction in arterial hypertension women: The role of depression and anxiety
- 1 August 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 181, 96-100
Sexual dysfunction in arterial hypertension women: The role of depression and anxiety
- 1 February 2015
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 57, 16-20
Predictors of suicidal ideation in coronary artery disease
- 1 February 2015
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 57, 16-20
Predictors of suicidal ideation in coronary artery disease
- 1 February 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 172, 179-183
The utilization of unified protocols in behavioral cognitive therapy in transdiagnostic group subjects: A clinical trial
- 1 February 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 172, 179-183
The utilization of unified protocols in behavioral cognitive therapy in transdiagnostic group subjects: A clinical trial
- Open Access
- 1 January 2013
- Published by FapUNIFESP (SciELO) in Trends in Psychiatry and Psychotherapy
- Vol. 35 (2) , 134-140
Transdiagnostic treatment using a unified protocol: application for patients with a range of comorbid mood and anxiety disorders
OBJECTIVE: To evaluate the effectiveness of a unified cognitive-behavioral therapy protocol for group treatment of patients with a range of comorbid mood and anxiety disorders. METHODS: In this open-trial study, the unified protocol was followed for the psychotherapeutic treatment of 16 patients with comorbid mood and anxiety disorders, confirmed by the Mini International Neuropsychiatric Interview. Beck Depression and Anxiety Inventories, the World Health Organization Quality of Life evaluation instrument, and the ARIZONA scale of sexual function were used to evaluate progress in patients throughout the therapeutic process. RESULTS: All patients showed unipolar depressive disorder. Comorbidity with anxiety disorders was distributed as follows: generalized anxiety disorder, 13 (81.3%); panic disorder, 3 (18.8%); social anxiety disorder, 1 (6.3%); and post-traumatic stress disorder, 1 (6.3%). Improvement was observed in the signs and symptoms of depression (F = 78.62, p < 0.001) and anxiety (F = 19.64, p < 0.001), overall quality of life (F = 39.72, p < 0.001), physical domain (F = 28.15, p < 0.001)), psychological variables (F = 9.90, p = 0.007), social functioning (F = 36.86, p < 0.001), environmental variables (F = 27.63, p < 0.001), and sexuality (F = 13.13; p < 0.005). All parameters showed highly significant correlations (p < 0.01). CONCLUSION: An effort to establish one unified treatment protocol for a whole family of emotional disorders (primarily mood and anxiety disorders) showed benefits in the field of clinical psychology and for the treatment of patients. No other data were found in the literature describing the implementation of the unified protocol in a transdiagnostic group. Our results revealed statistically significant improvement in all variables, suggesting that the protocol proposed can become an important tool to improve quality of life, sexuality, and anxiety/depression symptoms in patients with different diagnoses.
- 1 January 2013
- Published by FapUNIFESP (SciELO) in Trends in Psychiatry and Psychotherapy
- Vol. 35 (2) , 134-140
Open AccessTransdiagnostic treatment using a unified protocol: application for patients with a range of comorbid mood and anxiety disorders
OBJECTIVE: To evaluate the effectiveness of a unified cognitive-behavioral therapy protocol for group treatment of patients with a range of comorbid mood and anxiety disorders. METHODS: In this open-trial study, the unified protocol was followed for the psychotherapeutic treatment of 16 patients with comorbid mood and anxiety disorders, confirmed by the Mini International Neuropsychiatric Interview. Beck Depression and Anxiety Inventories, the World Health Organization Quality of Life evaluation instrument, and the ARIZONA scale of sexual function were used to evaluate progress in patients throughout the therapeutic process. RESULTS: All patients showed unipolar depressive disorder. Comorbidity with anxiety disorders was distributed as follows: generalized anxiety disorder, 13 (81.3%); panic disorder, 3 (18.8%); social anxiety disorder, 1 (6.3%); and post-traumatic stress disorder, 1 (6.3%). Improvement was observed in the signs and symptoms of depression (F = 78.62, p < 0.001) and anxiety (F = 19.64, p < 0.001), overall quality of life (F = 39.72, p < 0.001), physical domain (F = 28.15, p < 0.001)), psychological variables (F = 9.90, p = 0.007), social functioning (F = 36.86, p < 0.001), environmental variables (F = 27.63, p < 0.001), and sexuality (F = 13.13; p < 0.005). All parameters showed highly significant correlations (p < 0.01). CONCLUSION: An effort to establish one unified treatment protocol for a whole family of emotional disorders (primarily mood and anxiety disorders) showed benefits in the field of clinical psychology and for the treatment of patients. No other data were found in the literature describing the implementation of the unified protocol in a transdiagnostic group. Our results revealed statistically significant improvement in all variables, suggesting that the protocol proposed can become an important tool to improve quality of life, sexuality, and anxiety/depression symptoms in patients with different diagnoses.
- Open Access
Sexual dysfunction and cardiovascular diseases: a systematic review of prevalence
The aim of this study was to conduct a systematic review of the literature regarding the prevalence of sexual dysfunction in patients with cardiovascular diseases. An article search of the ISI Web of Science and PubMed databases using the search terms "sexual dysfunction", "cardiovascular diseases", "coronary artery disease", "myocardial infarct" and "prevalence" was performed. In total, 893 references were found. Non-English-language and repeated references were excluded. After an abstract analysis, 91 references were included for full-text reading, and 24 articles that evaluated sexual function using validated instruments were selected for this review. This research was conducted in October 2012, and no time restrictions were placed on any of the database searches. Reviews and theoretical articles were excluded; only clinical trials and epidemiological studies were selected for this review. The studies were mostly cross-sectional, observational and case-control in nature; other studies used prospective cohort or randomized clinical designs. In women, all domains of sexual function (desire, arousal, vaginal lubrication, orgasm, sexual dissatisfaction and pain) were affected. The domains prevalent in men included erectile dysfunction and premature ejaculation and orgasm. Sexual dysfunction was related to the severity of cardiovascular disease. When they resumed sexual activity, patients with heart disease reported significant difficulty, including a lack of interest in sex, sexual dissatisfaction and a decrease in the frequency of sexual activity.
Open AccessSexual dysfunction and cardiovascular diseases: a systematic review of prevalence
The aim of this study was to conduct a systematic review of the literature regarding the prevalence of sexual dysfunction in patients with cardiovascular diseases. An article search of the ISI Web of Science and PubMed databases using the search terms "sexual dysfunction", "cardiovascular diseases", "coronary artery disease", "myocardial infarct" and "prevalence" was performed. In total, 893 references were found. Non-English-language and repeated references were excluded. After an abstract analysis, 91 references were included for full-text reading, and 24 articles that evaluated sexual function using validated instruments were selected for this review. This research was conducted in October 2012, and no time restrictions were placed on any of the database searches. Reviews and theoretical articles were excluded; only clinical trials and epidemiological studies were selected for this review. The studies were mostly cross-sectional, observational and case-control in nature; other studies used prospective cohort or randomized clinical designs. In women, all domains of sexual function (desire, arousal, vaginal lubrication, orgasm, sexual dissatisfaction and pain) were affected. The domains prevalent in men included erectile dysfunction and premature ejaculation and orgasm. Sexual dysfunction was related to the severity of cardiovascular disease. When they resumed sexual activity, patients with heart disease reported significant difficulty, including a lack of interest in sex, sexual dissatisfaction and a decrease in the frequency of sexual activity.
- 1 November 2012
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 53 (8) , 1169-1173
Prevalence of psychiatric disorders in patients with diabetes types 1 and 2
- 1 November 2012
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 53 (8) , 1169-1173
Prevalence of psychiatric disorders in patients with diabetes types 1 and 2